The clinical impact of observer variability in lung nodule classification in children with Wilms tumour

Objectives To investigate the extent to which observer variability of computed tomography (CT) lung nodule assessment may affect clinical treatment stratification in Wilms tumour (WT) patients, according to the recent Société Internationale d'Oncologie Pédiatrique Renal Tumour Study Group (SIOP...

Full description

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 69; no. 10; pp. e29759 - n/a
Main Authors Brok, Jesper Sune, Shelmerdine, Susan, Damsgaard, Frederikke, Smets, Anne, Irtan, Sabine, Swinson, Sophie, Hedayati, Venus, Jacob, Joseph, Nair, Arjun, Oostveen, Minou, Pritchard‐Jones, Kathy, Olsen, Øystein
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To investigate the extent to which observer variability of computed tomography (CT) lung nodule assessment may affect clinical treatment stratification in Wilms tumour (WT) patients, according to the recent Société Internationale d'Oncologie Pédiatrique Renal Tumour Study Group (SIOP‐RTSG) UMBRELLA protocol. Methods I: CT thoraces of children with WT submitted for central review were used to estimate size distribution of lung metastases. II: Scans were selected for blinded review by five radiologists to determine intra‐ and inter‐observer variability. They assessed identical scans on two occasions 6 months apart. III: Monte Carlo simulation (MCMC) was used to predict the clinical impact of observer variation when applying the UMBRELLA protocol size criteria. Results Lung nodules were found in 84 out of 360 (23%) children with WT. For 21 identified lung nodules, inter‐observer limits of agreement (LOA) for the five readers were ±2.4 and ±1.4 mm (AP diameter), ±1.9 and ±1.8 mm (TS diameter) and ±2.0 and ±2.4 mm (LS diameter) at assessments 1 and 2. Intra‐observer LOA across the three dimensions were ±1.5, ±2.2, ±3.5, ±3.1 and ±2.6 mm (readers 1–5). MCMC demonstrated that 17% of the patients with a ‘true’ nodule size of ≥3 mm will be scored as <3 mm, and 21% of the patients with a ‘true’ nodule size of <3 mm will be scored as being ≥3 mm. Conclusion A significant intra–inter observer variation was found when measuring lung nodules on CT for patients with WT. This may have significant implications on treatment stratification, and thereby outcome, when applying a threshold of ≥3 mm for a lung nodule to dictate metastatic status.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.29759